Biogen, Eisai to shift some Alzheimer's drug production to US

Biogen, Eisai to shift some Alzheimer's drug production to US

TOKYO -- Japan's Eisai and American partner Biogen will transfer some production of active ingredients for their Alzheimer's disease treatment lecanem

Biogen Sues Ex-Collaborator Over Rights to Drug Tech - USA Herald

Biogen Inc. has filed a lawsuit against its former partner, Neurimmune Holding AG, over the rights to a novel therapeutic technology. The legal action, filed in the U.S. District Court for the District of Massachusetts, follows claims made by Neurimmune that it holds rights to a Biogen-developed therapeutic under a previous agreement. The dispute centers on an unrelated therapeutic that Biogen shared with Neurimmune in 2024 under a confidentiali…